Právní předpis byl sestaven k datu 20.02.2025.
Zobrazené znění právního předpisu je účinné od 08.03.2018.
Nařízení vlády, kterým se mění nařízení vlády č. 463/2013 Sb., o seznamech návykových látek, ve znění pozdějších předpisů
30/2018 Sb.
30
XXXXXXXX VLÁDY
ze xxx 31. xxxxx 2018,
xxxxxx xx xxxx xxxxxxxx xxxxx č. 463/2013 Sb., x xxxxxxxxx xxxxxxxxxx látek, xx xxxxx xxxxxxxxxx xxxxxxxx
Xxxxx xxxxxxxx xxxxx §44c odst. 1 xxxxxx č. 167/1998 Xx., o xxxxxxxxxx xxxxxxx x x xxxxx xxxxxxxxx xxxxxxx xxxxxx, xx xxxxx xxxxxx x. 273/2013 Xx.:
Xx. X
1. V §2 xx xxxxxxxxx xxxx označuje jako xxxxxxxx 1 x xxxxxxxx xx xxxxxxxx 2, xxxxx xxxxxx xxxxxxxx pod čarou x. 3 xxx:
"(2) Xxxx nařízení zapracovává xxxxxxxxx předpisy Evropské xxxx xxxxxxxx xx xxxxxxxxxx xxxxx3).
3) Rámcové xxxxxxxxxx Xxxx 2004/757/SVV xx dne 25. xxxxx 2004, xxxxxx xx xxxxxxx xxxxxxxxx xxxxxxxxxx xxxxxxxx xx xxxxx skutkových podstat xxxxxxxxx xxxx x xxxxxx x xxxxxxx xxxxxxxxxxxx xxxxxxx x xxxxxxx.
Xxxxxxxx Xxxxxxxxxx parlamentu x Xxxx (XX) 2017/2103 ze dne 15. xxxxxxxxx 2017, xxxxxx se xxxx xxxxxxx rozhodnutí Rady 2004/757/XXX s cílem xxxxxxxx xx definice xxxxx xxxx xxxxxxxxxxxxx xxxxx a xxxxxxx xxxxxxxxxx Xxxx 2005/387/XXX.".
2. Xxxxxxx x. 4 xxx:
"Xxxxxxx x. 4 x xxxxxxxx xxxxx x. 463/2013 Xx.
Xxxxxx x. 4 psychotropních xxxxx
Xxxxxxxxxxx nechráněný xxxxx (XXX) x českém xxxxxx / xxxxxx xxxxx |
Xxxxx xxxxxxxxxxx xxxxxxxxxx xxxxx nebo další xxxxxx xxxxx |
Xxxxxxxx xxxxx xxxxx XXXXX |
Xxxxxxxx |
XX-XXXXXXXX |
X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XX-XXXXXXXX |
X-(1-xxxxx-3-xxxxxx-1-xxxxxxxx-2-xx)-1-(4-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XX-XXXXXX |
X-[(1X)-1-(xxxxxxxxxxxxx)-2-xxxxxxxxxxxx]-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
4-Xxxxxxx-X-xxxxxx-X-xxxxxxxxxxxxxx |
4-XxX-XXX |
{3-[2-(xxxxxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx}xxxxxx |
|
x-Xxxxxxxxxxxxxx |
4-XxX-XXX |
{3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx}xxxxxx |
Xxxxxxxxxx |
XXX-XXXXXXXX |
X-[1-(xxxxxxxxxxxxx)-2,2-xxxxxxxxxxxxxx]-1-(xxxxxxxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxxxx |
||
XXX-XXXXXX |
X-(1-xxxxx-3,3-xxxxxxxx-1-xxxxxxxx-2-xx)-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx |
||
XX-7921 |
3,4-xxxxxxx-X-{[1-(xxxxxxxxxxxxx)xxxxxxxxxx]xxxxxx}xxxxxxxx |
||
XX-XXX |
(6xX,9X)-7-xxxxx-X,X-xxxxxxx-6,6x,8,9-xxxxxxxxxx-4X-xxxxx[4,3-xx]xxxxxxxx-9-xxxxxxxxxx |
6-xxxxx-6-xxx-XXX |
|
XX-2201 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-XXXXXXXX |
XXX-XXX |
Xxxxxx 2-({1-[(4-xxxxxxxxxx)xxxxxx]-1X-xxxxxxx-3-xxxxxxxx}xxxxx)-3-xxxxxxxxxxxxxx |
XXX-XXXXXXXX |
XXX-XXXXXX |
Xxxxxx (2X)-2-{[1-(xxxxxxxxxxxxxxxx)xxxxx-3-xxxxxxxx]xxxxx}-3-xxxxxxxxxxxxxx |
||
5-Xxxxxxxxxxxxxxxx |
5-XXX |
5-(2-xxxxxxxxxxx)xxxxx |
|
XXXXX |
XXX-001, 2NE1 |
N-(adamantan-1-yl)-1-pentyl-1H-indol-3-karboxamid |
|
APINACA |
N-(adamantan-1-yl)-1-pentyl-1H-indazol-3-karboxamid |
AKB48 |
|
bk-PMA |
2-amino-1-(4-methoxyfenyl)propan-1-on |
||
Methedron |
bk-PMMA |
1-(4-methoxyfenyl)-2-(methylamino)propan-1-on |
|
2-Brommethkathinon |
2-BMC |
(RS)-1-(2-bromfenyl)-2-(methylamino)propan-1-on |
|
3-Brommethkathinon |
3-BMC |
(RS)-1-(3-bromfenyl)-2-(methylamino)propan-1-on |
|
4-Brommethkathinon |
4-BMC |
(RS)-1-(4-bromfenyl)-2-(methylamino)propan-1-on |
Brefedron |
25B-NBOMe |
2-(4-brom-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin |
Cimbi-36 |
|
25C-NBOMe |
2-(4-chlor-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin |
2C-C-NBOMe |
|
25I-NBOH |
2-{[2-(4-jod-2,5-dimethoxyfenyl)ethylamino]methyl}fenol |
2C-I-NBOH; Cimbi-27 |
|
25I-NBOMe |
2-(4-jod-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin |
NBOMe-2C-I |
|
Bromo-Dragonfly |
(2R)-1-(4-bromfuro[2,3-f][1]benzofuran-8-yl)propan-2-amin |
||
Butylon |
Bk-MBDB |
2-(methylamino)-1-[3,4-(methylendioxy)fenyl]butan-1-on |
B1 |
2-Chloramfetamin |
2-CA |
1-(2-chlorfenyl)propan-2-amin |
|
3-Chloramfetamin |
3-CA |
1-(3-chlorfenyl)propan-2-amin |
|
4-Chloramfetamin |
4-CA |
1-(4-chlorfenyl)propan-2-amin |
PCA |
2-Chlorethkathinon |
2-CEC |
1-(2-chlorfenyl)-2-(ethylamino)propan-1-on |
|
3-Chlorethkathinon |
3-CEC |
1-(3-chlorfenyl)-2-(ethylamino)propan-1-on |
|
4-Chlorethkathinon |
4-CEC |
1-(4-chlorfenyl)-2-(ethylamino)propan-1-on |
|
4-Chlorisobutyrfentanyl |
4-Cl-iBF |
N-(4-chlorfenyl)-2-methyl-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid |
|
2C-E |
2-(4-ethyl-2,5-dimethoxyfenyl)ethan-1-amin |
||
2-Chlormethamfetamin |
2-CMA |
1-(2-chlorfenyl)-N-methylpropan-2-amin |
|
3-Chlormethamfetamin |
3-CMA |
1-(3-chlorfenyl)-N-methylpropan-2-amin |
|
4-Chlormethamfetamin |
4-CMA |
1-(4-chlorfenyl)-N-methylpropan-2-amin |
p-CMA |
2-Chlormethkathinon |
2-CMC |
1-(2-chlorfenyl)-2-(methylamino)propan-1-on |
|
3-Chlormethkathinon |
3-CMC |
1-(3-chlorfenyl)-2-(methylamino)propan-1-on |
|
4-Chlormethkathinon |
4-CMC |
1-(4-chlorfenyl)-2-(methylamino)propan-1-on |
Clefedron |
2-Chlorpentedron |
2-CPD |
1-(2-chlorfenyl)-2-(methylamino)pentan-1-on |
|
3-Chlorpentedron |
3-CPD |
1-(3-chlorfenyl)-2-(methylamino)pentan-1-on |
|
4-Chlorpentedron |
4-CPD |
1-(4-chlorfenyl)-2-(methylamino)pentan-1-on |
|
4-Chlor-α-pyrrolidinovalerofenon |
4-Cl-α-PVP |
1-(4-chlorfenyl)-2-(pyrrolidin-1-yl)pentan-1-on |
|
CUMYL-4CN-BINACA |
SGT-78 |
1-(4-kyanobutyl)-N-(1-methyl-1-fenylethyl)indazol-3-karboxamid |
|
Cyklopentylfentanyl |
Cyclopentyl-F; XX-X |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxx]xxxxxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-2 |
[4-(xxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
2X-X-7 |
[4-(xxxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx |
|
XX-47,497 |
2-[(1X,3X)-3-xxxxxxxxxxxxxxxxx]-5-(2-xxxxxxxxxxx-2-xx)xxxxx |
||
XXX-13 |
(xxxxxxxx-1-xx)[4-(xxxxxxxxx)xxxxxxxx-1-xx]xxxxxxxx |
XX-13 |
|
XXXX |
1,4-xxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxxxxx |
2-(xxxxxxxxxxx)-2-xxxxx-xxxxxxxxxxxx |
||
Xxxxxxxxxxxx-2-xxxxx xxxxxxxx |
X-(2-xxxxxxxxxx)-1-(2-xxxxxxxxxx)xxxxxxxxx-4-xxxx |
||
Xxxxxxxxxxxx-4-xxxxx fentanyl |
N-(4-fluorfenyl)-1-(2-fenylethyl)piperidin-4-amin |
||
Dibutylon |
Bk-DMBDB |
1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)-1-butanon |
Methylbutylon |
Diclazepam |
2-chlorodiazepam |
7-chlor-5-(2-chlorfenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on |
Ro 5-3448 |
Xxxxxxxxxxxxxxxx |
XXX |
X,X-xxxxxxx-X-[2-(xxxxx-3-xx)xxxxx]xxxx |
|
5-Xxxxxxxxxxxxxxxxxxxxxxxxxxxx |
5-XXXXX; XXXX |
1-(2,3-xxxxxxxxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
|
Xxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
x-Xxxxxx-4-xxxxxxxxxxxxxx |
4,4'-XXXX |
4-xxxxxx-5-(4-xxxxxxxxxxx)-4,5-xxxxxxx-1,3-xxxxxx-2-xxxx |
x4-XXXX |
Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
3-(1,2-xxxxxxxxxxxxxx)-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx |
|
2,3-Xxxxxxxxxxxxxxxxxxx |
2,3-XXXX |
1-(2,3-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
2,4-Xxxxxxxxxxxxxxxxxxx |
2,4-XXXX |
1-(2,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3,4-Xxxxxxxxxxxxxxxxxxx |
3,4-XXXX |
1-(3,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxxxxxxxxxxx |
XXX |
X-[2-(xxxxx-3-xx)xxxxx]-X,X-xxxxxxxxxxxx |
|
Xxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
2,5-Xxxxxxxxx-4-xxxxxxxxxxxxxx |
XXX |
1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxxxx |
XXX, XXX |
(2XX)-1-(2,5-xxxxxxxxx-4-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
2,5-Xxxxxxxxx-4-xxxxxxxxxxxx |
XXX |
1-(4-xxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
5-XXXX |
1-(1-xxxxxxxxxx-5-xx)-X-xxxxxxxxxxx-2-xxxx |
||
6-XXXX |
1-(1-xxxxxxxxxx-6-xx)-X-xxxxxxxxxxx-2-xxxx |
||
Xxxxxxxxxxxx |
Xxxxxxx |
(2XX)-1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxx |
XXXXX; xx-XXXX |
1-(xxxxx[x][1,3]xxxxxx-5-xx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
X-xxxxx-xxxxxxxx |
XXX-XXX |
(6xX,9X)-X,X-xxxxxxx-7-xxxxx-4,6,6x,7,8,9-xxxxxxxxxxxxxx-[4,3-xx]xxxxxxxx-9-xxxxxxxxxx |
||
Xxxxxxxx |
XXX 3219; Depas |
4-(2-chlorfenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin |
|
Ethylfenidát |
(RS)-ethyl-2-fenyl-2-piperidin-2-ylacetát |
||
2-Ethylmethkathinon |
2-EMC |
(RS)-2-methylamino-1-(2-ethylfenyl)propan-1-on |
|
3-Ethylmethkathinon |
3-EMC |
(RS)-2-methylamino-1-(3-ethylfenyl)propan-1-on |
|
4-Ethylmethkathinon |
4-EMC |
(RS)-2-methylamino-1-(4-ethylfenyl)propan-1-on |
|
Etryptamin |
3-(2-aminobutyl)indol |
||
2-Fluoramfetamin |
2-FA |
1-(2-fluorfenyl)propan-2-amin |
|
3-Fluoramfetamin |
3-FA |
1-(3-fluorfenyl)propan-2-amin |
|
4-Fluoramfetamin |
4-FA |
1-(4-fluorfenyl)propan-2-amin |
|
5F-ADBICA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluorpentyl)-1H-indol-3-karboxamid |
||
5F-AKB48 |
N-(adamantan-1-yl)-1-(5-fluorpentyl)-1H-indazol-3-karboxamid |
||
5F-AMB-PINACA |
5F-AMB |
Methyl-2-({[1-(5-fluorpentyl)-1H-indazol-3-yl]karbonyl}amino)-3-methylbutanoát |
5F-AMP |
Fentanyl xxxxxxxxx xxxxxx |
Xxxxxxxxxxxxx |
X-xxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]-xxxxxxxxx |
|
3X-Xxxxxxxxxxx |
3-XXX; XXX-593 |
2-(3-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|
4X-Xxxxxxxxxxx |
4-XXX |
2-(4-xxxxxxxxxxx)-3-xxxxxxxxxxxxxx |
|
4-Xxxxx-xxxxxxxxxxxxx |
4X-XX |
X-(4-xxxxxxxxxxx)-X-[(1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx)]xxxxxxxxx |
|
2-Xxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxx)xxxxxx-1-xx |
|
2-Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
X-(2-xxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
2-XX, x-XX |
3-Xxxxxxxxxxxxx |
Xxxxxxxxxxxxxxxxx |
X-(3-xxxxxxxxxx)-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
3-XX, x-XX |
4-Xxxxxxxxxxxxxxxxxxxxx |
4X-xXX |
X-(4-xxxxxxxxxx)-2-xxxxxx-X-[1-(2-xxxxxxxxxx)-4-xxxxxxxxxxx]xxxxxxxxxx |
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
(XX)-1-(2-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
(XX)-1-(3-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
(XX)-1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
Xxxxxxxxx |
4-Xxxxxxxxxxxxxxxxxx |
4X-XXX; 4-XXXX |
Xxxxxx-2-(4-xxxxxxxxxx)-2-(2-xxxxxxxxx)xxxxxx |
4X-XXX |
5X-XX-22; 5X-XXXXX |
8-xxxxxxxxxx xxxxx xxxxxxxx 1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxxx |
||
5X-XXXX-XXXXXX |
5X-XXX |
xxxxxx (X)-2-({[1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xx]xxxxxxxx}xxxxx)-3,3-xxxxxxxxxxxxxxxx |
|
5XXX-144 |
[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXX-11 |
|
Xxxxxxxxxxxxxxx |
XX-X |
X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]-xxxxx-2-xxxxxxxxxx |
2-xxxxxxxxxxxxxxxx |
4-Xxxxxxx-X-xxxxxx-X-xxxxx xxxxxxxxx |
4-XX-XXX |
3-{2-[xxxxx(xxxxxx)xxxxx]xxxxx}-1X-xxxxx-4-xx |
Xxxxxxx; Xxxxxxxxxxx |
4-Xxxxxxx-X-xxxxxx-X-xxxxxxxxx xxxxxxxxx |
4-XX-XxXX |
3-{2-[xxxxxx(xxxxxx-2-xx)xxxxx]xxxxx}-1X-xxxxx-4-xx |
Xxxxxxxx |
Xxxxxxxxxxxxxxxxxxx |
(2XX)-X-xxxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
||
(xxx)Xxxxxxx-X-xxxxxxxx N-benzyl xxxxxx |
X-(1-xxxxxxxxxxxxxxx-4-xx)-X-(4-xxxxxxxxxx)xxxxxxxxx |
||
Xxxxxxxxxxxxxxxxxxxxxxxx |
2X-X |
(4-xxx-2,5-xxxxxxxxxxxxxxxxxxx)xxxx |
|
XXX-018 |
(xxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-073 |
(1-xxxxx-1X-xxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-081 |
(4-xxxxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-122 |
(4-xxxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-200 |
[1-(2-xxxxxxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx |
||
XXX-210 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx |
||
XXX-250 |
2-(2-xxxxxxxxxxxx)-1-(1-xxxxxx-1X-xxxxx-3-xx)xxxxx-1-xx |
||
XXX-398 |
(4-xxxxxxxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3 -xx)xxxxxxxx |
||
Xxxxxxxx |
(2X)-2-xxxxx-1-xxxxxxxxxxx-1-xx |
||
(+)-Xxxxxxxx |
XXX, XXX-25 |
(+)-8β-(3,3-xxxxxxxxxxxxxx)-6-xxxxxx-9,10-xxxxxxxxxxxxxxxx |
|
1x-XXX, 1X-XXX |
xxxxxxxxxxx kyseliny 1-propionyl xxxxxxxxx; (6xX,9X)-X,X-xxxxxxx-7-xxxxxx-4-xxxxxxxxx-6,6x,8,9-xxxxxxxxxxxxxxx[4,3-xx]xxxxxxxx-9-xxxxxxxxxx |
||
5-XxX-XxXX |
X-[2-(5-xxxxxxx-1X-xxxxx-3-xx)xxxxx]-X-xxxxxxxxxxxx-2-xxxx; 5-methoxy-N-methyl-N-iso-propyl xxxxxxxxx |
||
Xxxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxxxxxxx)-2-xxxxxxxxxx]xxxxxxxxx |
2-XxX-xxxxxxxxx |
Xxxxxxxxxxxxxxxxxxxxx |
Xxxxxxx-XxX |
2-xxxxxxx-X-xxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
2-Xxxxxxxxxxxxxxx |
2-XX |
(2XX)-1-(2-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxxx |
3-XX |
(2XX)-1-(3-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
4-Xxxxxxxxxxxxxxx |
4-XX |
(2XX)-1-(4-xxxxxxxxxxx)xxxxxx-2-xxxx |
|
2-XXXX |
1-(xxxxxxxxxx-2-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
3-XXXX |
1-(xxxxxxxxxx-3-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
4-XXXX |
1-(xxxxxxxxxx-4-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
5-XXXX |
1-(xxxxxxxxxx-5-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
6-XXXX |
1-(xxxxxxxxxx-6-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
7-XXXX |
1-(xxxxxxxxxx-7-xx)-X-xxxxxxxxxxxx-2-xxxx |
||
XXXX |
1-xxxxxx-4-xxxxxxxxxxxxxxx |
||
2-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
2-XXXX |
1-(2-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
3-XXXX |
1-(3-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxx-X,X-xxxxxxxxxxxxxxxx |
4-XXXX |
1-(4-xxxxxxxxxxx)-2-(xxxxxxxxxxxxx)xxxxxx-1-xx |
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(3-xxxxxxxxxx)xxxxxxxxx |
|
Xxxxxxxxxxxx |
XXX |
(2XX)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
XXXX |
5,6-(xxxxxxxxxxxxx)xxxxx-2-xxxx |
||
Xxxxxxxxxxxxxxxxx |
XXX, MDEA |
(2RS)-N-ethyl-1-[3,4-(methylendioxy)fenyl]propan-2-amin |
|
Ethylon |
bk-MDEA |
2-ethylamino-1-(3,4-methylendioxyfenyl)propan-1-on |
|
Methyltenamfetamin |
MDMA |
(2RS)-N-methyl-1-[3,4-(methylendioxy)fenyl]propan-2-amin |
|
MDMB-CHMICA |
N-[[1-(cyklohexylmethyl)-1H-indol-3-yl]karbonyl]-3-methyl-valin, methyl xxxxx |
||
XXXX-XXXXXXXX |
2-[[1-[(4-xxxxxxxxxx)xxxxxx]xxxxxxx-3-xxxxxxxx]xxxxx]-3,3-xxxxxxxxxxxxxxxx |
||
XXXXX; 3,4-XXXXX |
1-(1,3-xxxxxxxxxxx-5-xx)-2-(xxxxxxxxxx-1-xx)xxxxx-1-xx |
||
2,3-Xxxxxxxxxxxxxxxxxxxxxxxxx |
2,3-XXXX |
1-(1,3-xxxxxxxxxxx-4-xx)-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
3,4-Xxxxxxxxxxxxxxxxxxxxxxxx |
XXXX |
1-[3,4-(xxxxxxxxxxxxx)xxxxx]-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
XXXX |
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
2-(xxxxxxxxxx)-1-(2-xxxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
2-(xxxxxxxxxx)-1-(3-xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxx |
4-XXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
4-Xxxxxxxxxxxxxxxxx |
Xxxxxxxx |
2-(xxxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx |
|
5-XxX-XXX |
5-xxxxxxx-α-xxxxxxxxxxxxxxx |
||
4-Xxxxxxxxxxxx fentanyl |
4-MeO-BF |
N-(4-methoxyfenyl)-N-[1-(2-fenylethyl)piperidin-4-yl]butanamid |
|
5-MeO-DALT |
N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-(prop-2-en-1-yl)prop-2-en-1-amin |
||
3 -Xxxxxxx xxxxxxxxxxx |
3-XxX-XXX |
1-[1-(3-xxxxxxxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|
Xxxxxxxx |
3,4,5-xxxxxxxxxxxxxxxxxxxxxx |
||
Xxxxxxxxxxxx |
XXX |
2-(xxxxxxxxxx)-2-(3-xxxxxxxxxxxx)xxxxxxxxxxxx |
|
Xxxxxxxxxxxxxx |
(±)-5-xxxxx-4-xxxxxx-4,5-xxxxxxxxxxxxx-2-xxxx |
||
α-Xxxxxxxxxxxxxx xxxxxxxxx xxxxxx |
XX; X-X |
2-xxxxxx-X-xxxxx-X-[1-(1-xxxxxxxxxxx-2-xx)xxxxxxxxx-4-xx]xxxxxxxxxx |
|
2-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
2-XXXX |
2-(xxxxxxxxxx)-1-(2-xxxxxxxxxxx)-xxxxxx-1-xx |
|
3-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
3-XXXX |
2-(xxxxxxxxxx)-1-(3-xxxxxxxxxxx)-xxxxxx-1-xx |
|
4-Xxxxxx-X-xxxxxxxxxxxxxxxxx |
4-XXXX |
2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)-xxxxxx-1-xx |
|
Xxxxxxxx |
Xx-XXXX |
2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-1-xx |
|
2-Xxxxxxxxxxxxxxxxxx |
2-XXX |
1-(2-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxxxxxx |
3-XXX |
1-(3-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
4-Xxxxxxxxxxxxxxxxxx |
4-XXX |
1-(4-xxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
2-Xxxxxxxxxxxxxxxxx |
2-XXX |
2-(xxxxxxxxxxx)-1-(2-xxxxxxxxxxx)xxxxxx-1-xx |
|
3-Xxxxxxxxxxxxxxxxx |
3-XXX |
2-(xxxxxxxxxxx)-1-(3-xxxxxxxxxxx)xxxxxx-1-xx |
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
(2XX)-1-[5-xxxxxxx-3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
4-XXX |
1-(4-xxxxxxxxxxx)-2-xxxxxxxxxxx-xxxxxx-1-xx |
||
Xxxxxxxxxxxxxxxxxxxxx |
XXX |
X-xxxxxx-1-(xxxxxxx-2-xx)xxxxxx-2-xxxx |
|
XX-45 |
1-xxxxxxxxxx-4-(1,2-xxxxxxxxxxxx)xxxxxxxxx |
||
2-Xxxxxxxxxxxxxxxxxxx |
2-XXX |
(2XX)-1-[2-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
3-Xxxxxxxxxxxxxxxxxxx |
3-XXX |
(2XX)-1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx |
|
4-Xxxxxxxxxxxxxxxxxxx |
4-XXX |
(2XX)-1-[4-(xxxxxxxxxxxxxx)xxxxxxxxxxxx-2-xxxx |
|
Xxxxxxxx |
4-XXX-xXx; XXX |
(3-xxxxxxx-2-(xxxxxxxxxxx)-1-(x-xxxxx)xxxxxx-1-xx |
|
Xxxxxxxxxxxxxxxxx |
Xxxxxxx |
1-(xxxxxxxx-2-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx |
X-2482 |
X-xxxxxx-2-xxxxxxxxxx |
X-xxxxxx-2XX |
2,3-xxxxxxx-X-xxxxxx-1X-xxxxx-2-xxxx |
XX-2XX |
XX-2201, XXX-2201 |
xxxxxxxx-1-xx-1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xxxxxxxxxx |
||
XXxxxxxxxx |
X-3217 |
X-(2-xxxxxxxxxx)-2-xxxxxxx-X-[1-(2-xxxxxxxxxx)xxxxxxxxx-4-xx]xxxxxxxx |
|
x-Xxxxxxxxxxxxxxxxx |
XXX |
3-{-2-[(xxxxxxxxxxxxx)xxxxxx]-1-xxxxxxxxxxxxxxxxx}xxxxx |
|
Xxxxxxxxx |
3-xxxxx-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx |
||
Xxxxxxxxxxx |
XXX |
X-xxxxx-1-xxxxxxxxxxxxxxxxxxx |
|
Xxxxxxxxx |
xxxxxxxxx |
1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx |
|
x-Xxxxxxxxxxxxxxxxxxx |
xXXX |
1-(4-xxxxxxxxxx)xxxxxxxxx |
|
Xxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(4-xxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxx |
XXXX |
1-(4-xxxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx |
|
Xxxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx-xxxxxxxxxxxxxxxx |
||
Xxxxxxxx |
Xxxxxxxxx |
3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx |
|
XX8, α-PHPP |
1-fenyl-2-(pyrrolidin-1-yl)-1-heptan-1-on |
||
PV9, α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxx-1-xx |
||
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
||
α-XXX |
2-(xxxxxxxxxx-1-xx)-1-(xxxxxxx-2-xx)xxxxxx-1-xx |
||
α-Xxxxxxxxxxxxxxxxxxxxxx |
α-XXX |
1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxx-1-xx |
|
α-Xxxxxxxxxxxxxxxxxxxxxxxxx |
α-XxXX |
1-xxxxx-4-xxxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx |
|
Xxxxxxxxxxxx |
XXX, XXXX |
1-(1-xxxxxxxxxxxxxxx)xxxxxxxxxx |
|
Xxxxxxxxxx X |
Xxxxxxxxxx X |
xxxxxx-(2XX,4xX,6xX,7X,9XX,10xXX,10xX)-9-xxxxxxx-2-(xxxxx-3-xx)-6x,10x-xxxxxxxx-4,10-xxxxxxxxxxxxxxxx-1X-xxxxx[x] xxxxxxxxxx-7-xxxxxxxxxx |
|
Xxxxxxxxxxxx |
XXX |
1-[1-(2-xxxxxxx)xxxxxxxxxx]xxxxxxxxx |
|
1-(3-Xxxxxxxxxxxxxxxxxxx)xxxxxxxxx |
XXXXX |
1-[3-(xxxxxxxxxxxxxx)xxxxx]xxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxxxxxx |
XXX-X |
X-(1-xxxxxxxxxxxxxxxxxx-4-xx)-X-xxxxxxxxxxxxxxxxxxxx-2-xxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
∆6x(10x)-,∆6x(7)-,∆7-,∆8-,∆10-,∆9(11)-xxxxxxxxxxxxxxxxxxxx x jejich xxxxxxxxxxxxx |
|
Xxxxxxxxxxxxxxxxxxx |
XXX |
(2XX)-1-(3,4,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
Xxxxxxxxxxxxxxxxxxx-2 |
XXX-2 |
(2XX)-1-(2,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
2,4,6-Xxxxxxxxxxxxxxxxxxx |
XXX-6 |
1-(2,4,6-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx |
|
XX-144 |
(1-xxxxxx-1X-xxxxx-3-xx)-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx |
XXXX-018 |
|
X-47700 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
X-49900 |
3,4-xxxxxxx-X-[2-(xxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
X-51,754 |
2-(3,4-xxxxxxxxxxxx)-X-[2-(xxxxxxxxxxxxx)xxxxxxxxxx]-X-xxxxxxxxxxxxxx |
||
Xxxxxxxxxxxxxxx |
XXX, VF |
N-fenyl-N-[1-(2-fenylethyl)-4-piperidyl]pentanamid; fentanyl xxxxxxxxxx analog |
|
W-15 |
4-chlor-N-(1-fenethylpiperidin-2-yliden)benzensulfonamid |
||
W-18 |
4-chlor-N-(1-[2-(4-nitrofenyl)ethyl]-piperidin-2-yliden)benzensulfonamid |
Včetně stereoizomerů xxxxxxxxxxxxxx látek, xx xx xxxxxxxx xxxxxxx, xxxxxxxxx x tomto xxxxxxx xx xxxxx xxxxxxxxx, xxx tyto xxxxxxxxxxxxx mohou xxxxxxxxx xxx xxxxxxxxxx xxxxxxxxxx xxxxxxxx x xxxx xxxxxxxxxxxxxx látek uvedených x tomto xxxxxxx xx všech xxxxxxxxx, xxx xxxxx existovat.".
Xx. XX
Xxxx xxxxxxxx xxxx xxxxxxxx v xxxxxxx xx směrnicí Xxxxxxxxxx parlamentu a Xxxx (XX) 2015/1535 xx dne 9. xxxx 2015 o xxxxxxx při poskytování xxxxxxxxx v xxxxxxx xxxxxxxxxxx xxxxxxxx x xxxxxxxx pro xxxxxx xxxxxxxxxx xxxxxxxxxxx.
Čl. XXX
Xxxx nařízení xxxxxx xxxxxxxxx xxxxxxxxx xxxx po xxxx xxxxxxxxx.
Xxxxxxxx vlády:
Ing. Xxxxx x. r.
Ministr xxxxxxxxxxxxx:
Xxx. xx Mgr. Vojtěch x. r.
Informace
Právní xxxxxxx x. 30/2018 Xx. xxxxx xxxxxxxxx xxxx 8.3.2018.
Xxxxx xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx xxxxx uvedeného xxxxxxxx xxxxxxxx.